Thomas, Gregory
Hirter, Kristen
Frederick, Elizabeth
Hausburg, Melissa
Bar-Or, Raphael
Mulugeta, Yetti
Roshon, Michael
Mains, Charles
Bar-Or, David
Article History
Received: 13 December 2021
Accepted: 14 February 2022
First Online: 3 March 2022
Declarations
:
: Not applicable. All experiments referred to in this report were conducted with commercially available cell lines and/or primary human cells with all appropriate consents available from the suppliers.
: Not applicable
: G.T and R.B-O are employees, shareholders, and have been granted stock options at Ampio Pharmaceuticals. E.F. and Y.M are employees and have been granted stock options at Ampio Pharmaceuticals. K.H. is a contract employee of Ampio Pharmaceuticals. M.H. owns stock options and is a shareholder and consultant of Ampio Pharmaceuticals. D.B-O is a director and shareholder at Ampio Pharmaceuticals. All other authors have nothing to declare.